[A case of embryonal carcinoma successfully treated by neoadjuvant chemotherapy: report of a case]. 1996

S Shibata, and T Okumichi, and A Kimura, and Y Nishimura, and H Okamoto, and T Kuraoka, and I Yuuki, and H Kajiwara
Department of Surgery, Yoshijima Hospital, Hiroshima, Japan.

A 20-year-old man was admitted with a complaint of cough and dyspnea. Chest X-ray revealed a large anterior mediastinal tumor. On chest CT scan, the inferior vena cava was found to be enclosed, and tumor invasion to the right pulmonary artery and left atrium was observed. The serum alpha-fetoprotein (AFP) level was increased. A diagnosis of primary mediastinal embryonal carcinoma was made by the needle biopsy. After three courses of chemotherapy, consisting of cisplatin, etoposide and bleomycin, the tumor became smaller and the serum AFP level became normal. Complete resection of the tumor was performed successfully. The resected tumor showed no evidence of active disease. The patient has been free of the disease for 3 years.

UI MeSH Term Description Entries
D008297 Male Males
D008479 Mediastinal Neoplasms Tumors or cancer of the MEDIASTINUM. Cancer of Mediastinum,Mediastinal Cancer,Cancer of the Mediastinum,Mediastinum Cancer,Mediastinum Neoplasms,Neoplasms, Mediastinal,Cancer, Mediastinal,Cancer, Mediastinum,Cancers, Mediastinal,Cancers, Mediastinum,Mediastinal Cancers,Mediastinal Neoplasm,Mediastinum Cancers,Mediastinum Neoplasm,Neoplasm, Mediastinal,Neoplasm, Mediastinum,Neoplasms, Mediastinum
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D005047 Etoposide A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle. Demethyl Epipodophyllotoxin Ethylidine Glucoside,Celltop,Eposide,Eposin,Eto-GRY,Etomedac,Etopos,Etoposide Pierre Fabre,Etoposide Teva,Etoposide, (5S)-Isomer,Etoposide, (5a alpha)-Isomer,Etoposide, (5a alpha,9 alpha)-Isomer,Etoposide, alpha-D-Glucopyranosyl Isomer,Etoposido Ferrer Farma,Exitop,Lastet,NSC-141540,Onkoposid,Riboposid,Toposar,VP 16-213,VP-16,Vepesid,Vépéside-Sandoz,Eto GRY,Etoposide, alpha D Glucopyranosyl Isomer,NSC 141540,NSC141540,Teva, Etoposide,VP 16,VP 16 213,VP 16213,VP16,Vépéside Sandoz,alpha-D-Glucopyranosyl Isomer Etoposide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D017024 Chemotherapy, Adjuvant Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment. Adjuvant Chemotherapy,Drug Therapy, Adjuvant,Adjuvant Drug Therapy
D018236 Carcinoma, Embryonal A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumors. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, p1595) Carcinomas, Embryonal,Embryonal Carcinoma,Embryonal Carcinomas

Related Publications

S Shibata, and T Okumichi, and A Kimura, and Y Nishimura, and H Okamoto, and T Kuraoka, and I Yuuki, and H Kajiwara
November 1984, Kyobu geka. The Japanese journal of thoracic surgery,
S Shibata, and T Okumichi, and A Kimura, and Y Nishimura, and H Okamoto, and T Kuraoka, and I Yuuki, and H Kajiwara
November 2011, Gan to kagaku ryoho. Cancer & chemotherapy,
S Shibata, and T Okumichi, and A Kimura, and Y Nishimura, and H Okamoto, and T Kuraoka, and I Yuuki, and H Kajiwara
November 2003, Internal medicine (Tokyo, Japan),
S Shibata, and T Okumichi, and A Kimura, and Y Nishimura, and H Okamoto, and T Kuraoka, and I Yuuki, and H Kajiwara
February 2014, Nagoya journal of medical science,
S Shibata, and T Okumichi, and A Kimura, and Y Nishimura, and H Okamoto, and T Kuraoka, and I Yuuki, and H Kajiwara
November 2012, Gan to kagaku ryoho. Cancer & chemotherapy,
S Shibata, and T Okumichi, and A Kimura, and Y Nishimura, and H Okamoto, and T Kuraoka, and I Yuuki, and H Kajiwara
April 2003, Gynecologic oncology,
S Shibata, and T Okumichi, and A Kimura, and Y Nishimura, and H Okamoto, and T Kuraoka, and I Yuuki, and H Kajiwara
October 2004, Hinyokika kiyo. Acta urologica Japonica,
S Shibata, and T Okumichi, and A Kimura, and Y Nishimura, and H Okamoto, and T Kuraoka, and I Yuuki, and H Kajiwara
July 2003, Gan to kagaku ryoho. Cancer & chemotherapy,
S Shibata, and T Okumichi, and A Kimura, and Y Nishimura, and H Okamoto, and T Kuraoka, and I Yuuki, and H Kajiwara
May 2020, Surgical case reports,
S Shibata, and T Okumichi, and A Kimura, and Y Nishimura, and H Okamoto, and T Kuraoka, and I Yuuki, and H Kajiwara
June 1965, Canadian Medical Association journal,
Copied contents to your clipboard!